Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC
Treatment of EGFR mutant non-small cell lung cancer (NSCLC) often develops resistance to EGFR TKIs. In this study, the authors discover a non-canonical activation of β-catenin signaling through Notch3 as a mechanism of adaptation to and resistance to EGFR TKI treatment in NSCLC.
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f0b02e3948464f6081e96b751e406253 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f0b02e3948464f6081e96b751e406253 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f0b02e3948464f6081e96b751e4062532021-12-02T15:34:38ZNotch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC10.1038/s41467-018-05626-22041-1723https://doaj.org/article/f0b02e3948464f6081e96b751e4062532018-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-05626-2https://doaj.org/toc/2041-1723Treatment of EGFR mutant non-small cell lung cancer (NSCLC) often develops resistance to EGFR TKIs. In this study, the authors discover a non-canonical activation of β-catenin signaling through Notch3 as a mechanism of adaptation to and resistance to EGFR TKI treatment in NSCLC.Rajeswara Rao ArasadaKonstantin ShiloTadaaki YamadaJianying ZhangSeiji YanoRashelle GhanemWalter WangShinji TakeuchiKoji FukudaNobuyuki KatakamiKeisuke TomiiFumitaka OgushiYasuhiko NishiokaTiffany TalabereShrilekha MisraWenrui DuanPaolo FaddaMohammad A. RahmanPatrick Nana-SinkamJason EvansJoseph AmannElena E. TcheknevaMikhail M. DikovDavid P. CarboneNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-16 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Rajeswara Rao Arasada Konstantin Shilo Tadaaki Yamada Jianying Zhang Seiji Yano Rashelle Ghanem Walter Wang Shinji Takeuchi Koji Fukuda Nobuyuki Katakami Keisuke Tomii Fumitaka Ogushi Yasuhiko Nishioka Tiffany Talabere Shrilekha Misra Wenrui Duan Paolo Fadda Mohammad A. Rahman Patrick Nana-Sinkam Jason Evans Joseph Amann Elena E. Tchekneva Mikhail M. Dikov David P. Carbone Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC |
description |
Treatment of EGFR mutant non-small cell lung cancer (NSCLC) often develops resistance to EGFR TKIs. In this study, the authors discover a non-canonical activation of β-catenin signaling through Notch3 as a mechanism of adaptation to and resistance to EGFR TKI treatment in NSCLC. |
format |
article |
author |
Rajeswara Rao Arasada Konstantin Shilo Tadaaki Yamada Jianying Zhang Seiji Yano Rashelle Ghanem Walter Wang Shinji Takeuchi Koji Fukuda Nobuyuki Katakami Keisuke Tomii Fumitaka Ogushi Yasuhiko Nishioka Tiffany Talabere Shrilekha Misra Wenrui Duan Paolo Fadda Mohammad A. Rahman Patrick Nana-Sinkam Jason Evans Joseph Amann Elena E. Tchekneva Mikhail M. Dikov David P. Carbone |
author_facet |
Rajeswara Rao Arasada Konstantin Shilo Tadaaki Yamada Jianying Zhang Seiji Yano Rashelle Ghanem Walter Wang Shinji Takeuchi Koji Fukuda Nobuyuki Katakami Keisuke Tomii Fumitaka Ogushi Yasuhiko Nishioka Tiffany Talabere Shrilekha Misra Wenrui Duan Paolo Fadda Mohammad A. Rahman Patrick Nana-Sinkam Jason Evans Joseph Amann Elena E. Tchekneva Mikhail M. Dikov David P. Carbone |
author_sort |
Rajeswara Rao Arasada |
title |
Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC |
title_short |
Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC |
title_full |
Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC |
title_fullStr |
Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC |
title_full_unstemmed |
Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC |
title_sort |
notch3-dependent β-catenin signaling mediates egfr tki drug persistence in egfr mutant nsclc |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/f0b02e3948464f6081e96b751e406253 |
work_keys_str_mv |
AT rajeswararaoarasada notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT konstantinshilo notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT tadaakiyamada notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT jianyingzhang notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT seijiyano notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT rashelleghanem notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT walterwang notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT shinjitakeuchi notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT kojifukuda notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT nobuyukikatakami notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT keisuketomii notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT fumitakaogushi notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT yasuhikonishioka notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT tiffanytalabere notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT shrilekhamisra notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT wenruiduan notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT paolofadda notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT mohammadarahman notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT patricknanasinkam notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT jasonevans notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT josephamann notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT elenaetchekneva notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT mikhailmdikov notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc AT davidpcarbone notch3dependentbcateninsignalingmediatesegfrtkidrugpersistenceinegfrmutantnsclc |
_version_ |
1718386815537250304 |